PEDIATRIC DRUGS（儿科药物杂志）影响因子_期刊投稿发表

期刊简介

Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of review and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents. The Journal includes:-overviews of contentious or emerging issues.-comprehensive narrative reviews of topics relating to the effective and safe management of drug therapy through all stages of pediatric development.-practical reviews covering optimum drug management of specific clinical situations.-systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.-Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in the pediatric population.-original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pediatric Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

儿科药物促进对儿科药物治疗（包括疫苗）感兴趣的医疗保健专业人士的药物治疗的各个方面的优化和进步。综述和原创研究文章项目为医疗保健决策者提供了与新生儿学和儿童及青少年护理所有领域药物治疗相关问题的临床适用知识。《日刊》包括：-有争议或新出现问题的概述。全面的叙述性审查的主题有关的有效和安全的管理药物治疗的所有阶段的儿科发展。涵盖特定临床情况下的最佳药物管理的实际审查。系统性综述，使用PRISMA声明中概述的明确、系统的方法，整理经验证据以回答特定的研究问题。Adis药物评论的性质和地方在治疗中的新的和已建立的药物在儿科人群。报告与临床实践密切相关的精心设计的研究结果的原创研究文章，如临床药效学和药代动力学研究、临床试验、荟萃分析、结局研究、药物经济学和药物流行病学研究。（包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表播客和动画）可以与文章一起发布;目的是提高刊物的知名度、读者群和教育价值。此外，发表在《儿科药物》上的文章可能附有简明扼要的总结，以帮助对该领域有一定了解但没有深入专业知识的读者了解重要的医学进展。

《PEDIATRIC DRUGS》期刊已被查看：次

分区信息